Skip to content

The effect of salpingectomy on ovarian reserve

The effects of salpingectomy during hysterectomy on ovarian reserve :before and after clinical trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20120922010901N8
Enrollment
25
Registered
2020-12-29
Start date
2020-04-04
Completion date
Unknown
Last updated
2021-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ovarian reserve following salpingectomy.

Interventions

Intervention group: Women under 45 years of age are candidates for hysterectomy due to benign diseases in which salpingectomy is performed simultaneously with hysterectomy and the amount of antimuller

Sponsors

Tabriz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
15 Years to 45 Years

Inclusion criteria

Inclusion criteria: Women under 45 years is a candidate for histerectomy

Exclusion criteria

Exclusion criteria: Malignant disease women under 15 years premature ovarian failure before surgery

Design outcomes

Primary

MeasureTime frame
Changes in AMH levels following salpingectomy. Timepoint: AMH measurement the day before surgery and again three months after surgery. Method of measurement: From a blood sample with the same luminescence immunoassay (ICL) kit in the laboratory.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMustafa Gharabaghi Parvin

Tabriz University of Medical Sciences

Pm_gharabaghi@yahoo.com+98 41 3553 7492

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026